XBiotech Inc. (XBIT) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering XBiotech Inc. (XBIT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For XBiotech Inc., analysts forecast revenue rising from $28.00M in 2020 to $150.00M in 2023; the average estimate for 2023 earnings per share is $2.89; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
XBiotech Inc. (XBIT) forecast — frequently asked questions
What are analysts forecasting for XBiotech Inc.'s earnings?
The average analyst estimate for XBiotech Inc. (XBIT) earnings per share in 2023 is 2.89, with individual estimates between 2.89 and 2.89.
How much revenue is XBiotech Inc. expected to make?
Analysts forecast XBiotech Inc. (XBIT) revenue of $150.00M in 2023, based on 1 published estimates.
How many analysts cover XBIT?
1 analyst contribute estimates for XBiotech Inc. (XBIT). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.